Discover 1,436 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,436
Active & Responsive
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
for
Capsular Contracture Associated With Breast Implant,
Location: Seattle WA, Vancouver WA, Reno NV, Draper UT,
Sponsor: C. R. Bard
Sex: Female
Age: 22 - 70
Code: NCT05945329
Recruiting
Active & Responsive
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
for
Relapsing Multiple Sclerosis,
Location: Seattle WA, Portland OR, Palo Alto CA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT04047628
Phase3, Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Seattle WA, Bellevue WA, Kelowna, Red Deer,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase3, Recruiting
Active & Responsive
Contraceptive Efficacy Study of Ovaprene
for
Contraception
Location: Seattle WA, Phoenix AZ, Tucson AZ
Sponsor: Daré Bioscience, Inc.
Sex: Female
Age: 18 - 40
Code: NCT06127199
Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Location: Seattle WA, Kansas City KS, Park Ridge IL, Buffalo NY,
Sponsor: Cerus Endovascular, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06693011
Recruiting
Active & Responsive
Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury
for
Acute Spinal Cord Injury
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06654804
Recruiting
Active & Responsive
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Seattle WA, San Francisco CA, Redwood City CA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Location: Seattle WA, Vancouver, Los Angeles CA, Denver CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase2, Phase3, Recruiting
Active & Responsive
A Study of Brenipatide in Participants With Opioid Use Disorder
for
Opioid Use Disorder
Location: Seattle WA, Kelowna, Kamloops, Calgary,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07420283
Phase2, Recruiting
Active & Responsive
Microgrid II - Electrocorticography Signals for Human Hand Prosthetics
for
Epilepsy Intractable
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT03289572
Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Seattle WA, Portland OR, Sacramento CA,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase3, Recruiting
Active & Responsive
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
for
Diabetes Mellitus, Type 2,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 40 - 65
Code: NCT05780905
Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: Seattle WA, Vancouver, Salt Lake City UT,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer